Showing 65,381 - 65,400 results of 123,450 for search '(( 2 d decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.43s Refine Results
  1. 65381

    Alterations in biomarker protein expression compared against Gleason score. by Stephanie E. A. Burnell (7164608)

    Published 2019
    “…From Gleason 7, the protein expression appears to decrease in a step-wise manner towards Gleason 9/10. …”
  2. 65382

    The Effect of India's Total Sanitation Campaign on Defecation Behaviors and Child Health in Rural Madhya Pradesh: A Cluster Randomized Controlled Trial by Sumeet R. Patil (621729)

    Published 2014
    “…The intervention increased percentage of households in a village with improved sanitation facilities as defined by the WHO/UNICEF Joint Monitoring Programme by an average of 19% (95% CI for difference: 12%–26%; group means: 22% control versus 41% intervention), decreased open defecation among adults by an average of 10% (95% CI for difference: 4%–15%; group means: 73% intervention versus 84% control). …”
  3. 65383

    Model vs. WKY group KEGG pathways (Top 15). by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  4. 65384

    Behavioral data. by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  5. 65385

    OPLS-DA model parameter. by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  6. 65386

    Model vs. SHR group KEGG pathways (Top 15). by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  7. 65387

    Table 1_CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study.docx by Jingwei Yu (201422)

    Published 2025
    “…At a median follow-up of 8.5 months, the median PFS and OS were both not reached. …”
  8. 65388

    The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis by Ingrid Lindquist (262581)

    Published 2021
    “…Total periprocedural bleeding was decreased in patients who received TPO-RAs (11.6% vs 15.6%, RR 0.64, 95% CI 0.5–0.9 <i>p</i> = .01. …”
  9. 65389

    Diagnostic criteria for Alcoholic cardiomyopathy. by Fei Yan (128878)

    Published 2025
    “…</p><p><b>Results:</b> Globally, ACM burden showed significant declines from 1990 to 2021, with age-standardized rates decreasing by 22.5-37.1% across prevalence, mortality and disability measures. …”
  10. 65390

    Results from phylogenetic profile comparison of 635,628 pairs of proteins chosen from among a subset of 1,191 yeast proteins by Raja Jothi (31820)

    Published 2011
    “…The relative performances of all but one (BAE4) reference sets of genomes for yeast are almost the same as that for . A gradual decrease in performance can be noticed as the fraction of eukaryotic genomes in the reference set increases (BAE4, BAE5, BAE6, AE, E), which is counter-intuitive considering the fact that one would hope to see an improved performance on adding more eukaryotic genomes. …”
  11. 65391

    Data_Sheet_2_Role of Downregulation and Phosphorylation of Cofilin in Polarized Growth, MpkA Activation and Stress Response of Aspergillus fumigatus.PDF by Xiaodong Jia (783460)

    Published 2018
    “…Expression of non-phosphorylated cofilin with a mutation of S5A had little impacts on A. fumigatus, whereas expression of a mimic-phosphorylated cofilin with a mutation of S5E resulted in inhibited growth, increased phospho-MpkA level, and decreased pathogenicity. …”
  12. 65392

    BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System by Niklas Mattsson (144720)

    Published 2012
    “…In particular Aβ1-34 decreased, while Aβ5-40 increased, and these changes were more sensitive to BACE1 inhibition than the changes in Aβ1-40 and Aβ1-42. …”
  13. 65393

    Data_Sheet_1_Role of Downregulation and Phosphorylation of Cofilin in Polarized Growth, MpkA Activation and Stress Response of Aspergillus fumigatus.PDF by Xiaodong Jia (783460)

    Published 2018
    “…Expression of non-phosphorylated cofilin with a mutation of S5A had little impacts on A. fumigatus, whereas expression of a mimic-phosphorylated cofilin with a mutation of S5E resulted in inhibited growth, increased phospho-MpkA level, and decreased pathogenicity. …”
  14. 65394

    Supplementary Material for: The Incidence and Risk Factors of Infusion-Related Reactions to Rituximab for Treating B Cell Malignancies in a Single Tertiary Hospital by Jung J.-W. (4141510)

    Published 2014
    “…<b><i>Results:</i></b> A total of 389 cases of IRRs by rituximab (12.5% of a total of 3,104 infusions) were identified in 281 patients (49.4% of a total of 568 patients). …”
  15. 65395

    Image_1_The Burden of Gastrointestinal Complaints in Kidney Transplant Recipients Using Tacrolimus With and Without Mycophenolate Mofetil: A Randomized Controlled Study.jpeg by Zainab Al Fatly (13115601)

    Published 2022
    “…</p>Results<p>Seventy-nine recipients were randomized and 72 completed all questionnaires (34 TACmono and 38 TAC/MMF). At baseline, the mean age was 59 years with 72% male, mean BMI 28 kg/m<sup>2</sup>, eGFR 55 ml/min/1.73m2, mean daily dose MMF 1200 mg and TAC 5.8 mg, with trough levels of 2.1 mg/L and 7.4 ug/L. …”
  16. 65396

    Table_1_More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample.DOC by Britta Müller (654337)

    Published 2019
    “…A standardized questionnaire addressing headache and headache treatment was filled in during the face-to-face survey.…”
  17. 65397

    Image_1_Brazilian autoimmune encephalitis network (BrAIN): antibody profile and clinical characteristics from a multicenter study.tiff by Bruna de Freitas Dias (17281726)

    Published 2023
    “…The following antibodies were found: anti-NMDAR (n=79, 54%), anti-MOG (n=14, 9%), anti-LGI1(n=12, 8%), anti-GAD (n=11, 7%), anti-GlyR (n=7, 4%), anti-Caspr2 (n=6, 4%), anti-AMPAR (n=4, 2%), anti-GABA-BR (n=4, 2%), anti-GABA-AR (n=2, 1%), anti-IgLON5 (n=1, 1%), and others (n=5, 3%). Predictors of seropositive AIE in the pediatric population (n=42) were decreased level of consciousness (p=0.04), and chorea (p=0.002). …”
  18. 65398
  19. 65399
  20. 65400

    Longitudinal iGlu<sub>u</sub> imaging experiments reveal forskolin effect on hMFB glutamate release. by Marta Orlando (11001599)

    Published 2021
    “…(D) Graph shows the cumulative amplitude, active area, and mean and maximal amplitudes of the iGlu<sub>u</sub> fluorescent signal of the hMFB in (A and B). …”